Literature DB >> 8821004

The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage.

J L Heeremans1, H R Gerritsen, S P Meusen, F W Mijnheer, R S Gangaram Panday, R Prevost, C Kluft, D J Crommelin.   

Abstract

UNLABELLED: In this study, a method was developed for the efficient entrapment of active tissue-type Plasminogen Activator (t-PA) into liposomes. Experimental conditions were varied to optimize t-PA entrapment: different buffer solutions were used (pH 4 and 7.5), the effect of the incubation concentrations of phospholipid (PL) and t-PA was monitored and the influence of liposome-size was examined. Furthermore, the effect of ultracentrifugation on t-PA containing liposomes was determined in the presence and absence of Tween 80. t-PA entrapment strongly depended on experimental conditions and ranged from 30 up to 90%. Almost quantitative+ (90%) entrapment (entrapment percentage defined as absolute entrapment (IU t-PA/mumol PL) divided by total incubation ratio (IU t-PA/mumol PL), times 100%) was obtained in Hepes buffer pH 7.5, devoid of arginine, with low ionic strength. Ultracentrifugation, used for removal of non-entrapped t-PA, was shown to have a damaging effect on the liposomes (especially in the presence of 0.05% Tween 80), leading to t-PA loss. However, because acceptable alternatives were not available, ultracentrifugation was used during this study. Therefore, the encapsulation-percentage values shown in this study are in fact underestimates for the true entrapment of t-PA. IN
CONCLUSION: almost quantitative t-PA entrapment in liposomes can be achieved by selecting the proper milieu and inducing a strong interaction between t-PA and bilayer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821004     DOI: 10.3109/10611869509015959

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  15 in total

Review 1.  Translational initiatives in thrombolytic therapy.

Authors:  Melvin E Klegerman
Journal:  Front Med       Date:  2017-03-02       Impact factor: 4.592

2.  Delivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage.

Authors:  Andrzej S Pitek; Jooneon Park; Yunmei Wang; Huiyun Gao; He Hu; Daniel I Simon; Nicole F Steinmetz
Journal:  Nanoscale       Date:  2018-09-13       Impact factor: 7.790

3.  Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.

Authors:  Shan Liu; Xiaozhou Feng; Rong Jin; Guohong Li
Journal:  Expert Opin Drug Deliv       Date:  2017-09-28       Impact factor: 6.648

Review 4.  Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective.

Authors:  Deepak Solomon; Nilesh Gupta; Nihal S Mulla; Snehal Shukla; Yadir A Guerrero; Vivek Gupta
Journal:  AAPS J       Date:  2017-09-18       Impact factor: 4.009

5.  Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes.

Authors:  Susan D Tiukinhoy-Laing; Shaoling Huang; Melvin Klegerman; Christy K Holland; David D McPherson
Journal:  Thromb Res       Date:  2006-08-02       Impact factor: 3.944

6.  Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes.

Authors:  Denise A B Smith; Sampada S Vaidya; Jonathan A Kopechek; Shao-Ling Huang; Melvin E Klegerman; David D McPherson; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2010-01       Impact factor: 2.998

7.  Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes.

Authors:  George J Shaw; Jason M Meunier; Shao-Ling Huang; Christopher J Lindsell; David D McPherson; Christy K Holland
Journal:  Thromb Res       Date:  2009-02-13       Impact factor: 3.944

8.  Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study.

Authors:  Shuhua Bai; Vivek Gupta; Fakhrul Ahsan
Journal:  Eur J Pharm Sci       Date:  2009-07-16       Impact factor: 4.384

9.  Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.

Authors:  Shahriar Absar; Kamrun Nahar; Young Min Kwon; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2013-03-07       Impact factor: 4.200

10.  Drug release from nanomedicines: Selection of appropriate encapsulation and release methodology.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Ben J Boyd
Journal:  Drug Deliv Transl Res       Date:  2012-03-03       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.